Friday, May 19, 2017 9:19:47 AM
Aquinox stock rockets 2000%, Twitter goes nuts
There's plenty of examples of depressed small biotech companies whose stock price rocketed higher after approval. For example:
http://www.marketwatch.com/story/aquinox-stock-rockets-2000-twitter-goes-nuts-2015-08-10?siteid=bigcharts&dist=bigcharts
Investigating on your own and proper Due Diligence will help provide a better and more accurate perspective
There's plenty of examples of depressed small biotech companies whose stock price rocketed higher after approval. For example:
http://www.marketwatch.com/story/aquinox-stock-rockets-2000-twitter-goes-nuts-2015-08-10?siteid=bigcharts&dist=bigcharts
Shares of Canadian pharmaceutical company Aquinox Pharmaceuticals Inc. AQXP, +6.80% soared more than 2000% on an intraday basis over the last two trading sessions — and investors went insane about it on Twitter.
The rally started after the company released positive mid-stage trial results on Friday for a bladder pain drug referred to by its clinical name, AQX-1125. Shares traded up as much as 280% Monday morning after closing up nearly 500% on Friday
Investigating on your own and proper Due Diligence will help provide a better and more accurate perspective
Men who are occupied in the restoration of health to other men, by the joint exertion of skill and humanity, are above all the great of the earth. They even partake of divinity, since to preserve and renew is almost as noble as to create.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
